There Are Obvious Similarities Between Today’s Proliferation Of Pot Stocks And The California Gold Rush Of 1849.

It’s an exciting space to invest, though it’s clearly not risk-free with the federal government still looming. Wisely, SMG avoids the higher risk aspects of handling the substance, instead focusing on the lower-risk opportunity to simply supply the booming hydroponics industry. There are obvious similarities between today’s proliferation of “pot stocks” and the California Gold Rush of 1849. Not every prospector will make it. But the companies supplying those prospectors? That was where the smart money went in 1849 – the same is true today. Following the big money, like SMG, it’s clear why they’re investing heavily in the ability to “sell shovels” to cannabis handlers. SMG’s Hawthorne subsidiary and gardening segment accounted for about 13% of net sales last year, or $365 million, and the company reported 30% revenue growth from Hawthorne over the previous year. This was Hawthorne’s second full year in business. Solis Tek (OTCMKTS:SLTK) takes the same approach. The company is a manufacturer of digital lighting equipment (called “grow lights”) for the hydroponics industry. Solis Tek is one of these custom light providers, producing ballasts, reflectors, and Marijuana Stocks HID lights, with some of the most respected custom products on the market; Dope Magazine dubbed Solis Tek 2016’s “Best Lighting Company.” It may not sound as sexy as medicinal pot growing companies, but the market potential, and Solis Tek’s current growth and financials, are fundamentally sound.

To read more visit https://www.baystreet.ca/articles/stockstowatch.aspx?articleid=31202

But, Does He Stand By His Choice Of Selecting Them To Be A Part Of The Canopy Program Notwithstanding?

“Our investors very much fit that mold: they are high net worth individuals and they are family offices. We’ve got a total of about 40 to 45 investors who provide funding to our venture funds … and we protect them from immature entrepreneurs who are unable to get out of their own way.” We then moved on to discuss a few Canopy alumni who were not pleased with the results following the boot camp. “We make a lot of investments so I fully expect that 5 percent or 10 percent of our investments are going to go south and they’re going to end up failing. Sometimes those will cause some heartburn with different people,” the managing director answered. But, does he stand by his choice of selecting them to be a part of the Canopy program notwithstanding? Or does Tapman look back at it as a mistake? “I think it’s very easy to pretend like we made a mistake selecting some companies, but the reality is that you make decisions based on data that you have available at the time,” he said, sharing a sports metaphor. When a team wants to recruit a new athlete, it’s usually better to find a young man or woman with potential and invest in his/her future, instead of acquiring an extremely expensive, acclaimed athlete.

To read more visit Medical marijuana stocks href=’https://www.benzinga.com/news/17/06/9658646/pot-baron-on-canopyboulders-investments-we-focus-on-cos-that-can-scale-to-spectac’ rel=’nofollow’>https://www.benzinga.com/news/17/06/9658646/pot-baron-on-canopyboulders-investments-we-focus-on-cos-that-can-scale-to-spectac